Sodium cromoglicate inhalant - Patara Pharma

Drug Profile

Sodium cromoglicate inhalant - Patara Pharma

Alternative Names: Cromolyn sodium - Patara Pharma; Disodium cromoglicate; Inhaled sodium cromoglycate - Patara Pharma; PA-101; PA-101B

Latest Information Update: 13 Apr 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Patara Pharma
  • Class Antiallergics; Antiasthmatics; Antitussives; Benzopyrans; Chromones; Nootropics; Small molecules
  • Mechanism of Action Mast cell stabilisers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Cough; Pruritus; Systemic mastocytosis

Most Recent Events

  • 01 Dec 2016 Patara Pharma completes a phase II trial for Pruritus (Treatment-experienced) in USA (Inhalation) (NCT02696499)
  • 07 Sep 2016 Efficacy and adverse events data from a phase II trial in Cough (in patients with idiopathic pulmonary fibrosis) presented at the European Respiratory Society International Congress (ERS-2016)
  • 07 Sep 2016 Patara Pharma plans a phase IIb trial in Cough
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top